ACE Inhibitor and Angiotensin Receptor Blocker Use During Pregnancy: Data From the ESC Registry Of Pregnancy and Cardiac Disease (ROPAC)
Johanna A van der Zande(Erasmus MC), Magdalena Lipczyńska(Institute of Cardiology), Edit Nagy(Brigham and Women's Hospital), Arie Franx(Erasmus MC - Sophia Children’s Hospital), Edison Muñoz-Ortiz(Universidad de Antioquia), Tobias Rutz(University of Lausanne), Katja Prokšelj(Ljubljana University Medical Centre), Karishma P. Ramlakhan(Erasmus MC), Amalia Baroutidou(Aristotle University of Thessaloniki), Mark R. Johnson(Chelsea and Westminster Hospital NHS Foundation Trust), Roger Hall(University of East Anglia)
Cited by 9
Related Papers
Pathophysiology, Diagnosis and Management of Peripartum Cardiomyopathy: A Position Statement from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy
|European Journal of Heart Failure|2019|435
Clinical characteristics of patients from the worldwide registry on peripartum cardiomyopathy (PPCM)
|European Journal of Heart Failure|2017|232
Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: an ESC EORP registry
|European Heart Journal|2020|187